In vitro polarized transport of L-phenylalanine in human nasal epithelium and partial characterization of the amino acid transporters involved

被引:12
作者
Agu, R
Dang, HV
Jorissen, M
Willems, T
Vandoninck, S
Van Lint, J
Vandenheede, JV
Kinget, R
Verbeke, N
机构
[1] Katholieke Univ Leuven, Lab Pharmacotechnol & Biopharm, B-3000 Louvain, Belgium
[2] Katholieke Univ Leuven, Lab Expt Otorhinolaryngol, B-3000 Louvain, Belgium
[3] Katholieke Univ Leuven, Med Biochem Lab, B-3000 Louvain, Belgium
关键词
human nasal epithelium; nasal cell culture; active transport; cation-modulated broad-scope amino acid transporters; L-phenylalanine;
D O I
10.1023/A:1025028410131
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The purpose of this study was to provide functional and molecular evidence to support the existence of large neutral amino acid transporters in human nasal epithelium using nasal primary cell culture model. Methods. L-Phenylalanine was used as a model substrate to characterize carrier-mediated permeation of amino acids across human nasal epithelium. The influence of temperature, concentration, other amino acids, metabolic/transport inhibitors, and polarity/stereoselectivity on transport of the model compound was investigated. Reverse transcriptase polymerase chain reaction was used for molecular characterization of the existence of the transporters. Results. The transport of L-phenylalanine across the human nasal epithelium was polarized ( apical -> basolateral >> basolateral. apical), saturable (K-m = 1.23 mM; V-max = 805.1 nmol/mg protein/min) and stereo-selective ( permeation of L-phenylalanine >> D-Phenylalanine). Its permeation was significantly (<0.05) reduced by cationic, small and large neutral amino acids, oubain, amiloride, sodium-free medium, and temperature lowering. Reverse transcriptase polymerase chain reaction revealed the presence of the broad-scope cationic-dependent amino acid transporter gene (y(+) LAT-2) in the human nasal epithelium. Conclusions. Based on the results of this study, one may postulate that the human nasal epithelium expresses L-amino acid transporters. More studies are necessary for detailed characterization of the transporters.
引用
收藏
页码:1125 / 1132
页数:8
相关论文
共 32 条
[1]  
Agu RU, 2002, STP PHARMA SCI, V12, P81
[2]   Nasal absorption enhancement strategies for therapeutic peptides: an in vitro study using cultured human nasal epithelium [J].
Agu, RU ;
Dang, HV ;
Jorissen, M ;
Willems, T ;
Kinget, R ;
Verbeke, N .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 237 (1-2) :179-191
[3]   In-vitro nasal drug delivery studies: comparison of derivatised, fibrillar and polymerised collagen matrix-based human nasal primary culture systems for nasal drug delivery studies [J].
Agu, RU ;
Jorissen, M ;
Willems, T ;
Augustijns, P ;
Kinget, R ;
Verbeke, N .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (11) :1447-1456
[4]   Transport mechanisms of the large neutral amino acid L-phenylalanine in the human intestinal epithelial Caco-2 cell line [J].
Berger, V ;
Larondelle, Y ;
Trouet, A ;
Schneider, YJ .
JOURNAL OF NUTRITION, 2000, 130 (11) :2780-2788
[5]   STIMULATION OF SYSTEM Y+-LIKE AMINO-ACID-TRANSPORT BY THE HEAVY-CHAIN OF HUMAN 4F2 SURFACE-ANTIGEN IN XENOPUS-LAEVIS OOCYTES [J].
BERTRAN, J ;
MAGAGNIN, S ;
WERNER, A ;
MARKOVICH, D ;
BIBER, J ;
TESTAR, X ;
ZORZANO, A ;
KUHN, LC ;
PALACIN, M ;
MURER, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) :5606-5610
[6]   Cationic amino acid transport through system y+L in erythrocytes of patients with lysinuric protein intolerance [J].
Boyd, CAR ;
Deves, R ;
Laynes, R ;
Kudo, Y ;
Sebastio, G .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2000, 439 (05) :513-516
[7]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[8]   Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires different domains [J].
Bröer, A ;
Friedrich, B ;
Wagner, CA ;
Fillon, S ;
Ganapathy, V ;
Lang, F ;
Bröer, S .
BIOCHEMICAL JOURNAL, 2001, 355 (03) :725-731
[9]   Transfer of dopamine in the olfactory pathway following nasal administration in mice [J].
Dahlin, M ;
Bergman, U ;
Jansson, B ;
Bjork, E ;
Brittebo, E .
PHARMACEUTICAL RESEARCH, 2000, 17 (06) :737-742
[10]  
DANG HV, 2002, INT J PHARMACEUT, V238, P247